Relevance of GLP-1 receptor agonists or SGLT-2 inhibitors on the recruitment for clinical studies in patients with NAFLD

aDivision of Hepatology, Department of Medicine II, Leipzig University Medical Centre

bDivision of Gastroenterology, Department of Medicine II, Leipzig University Medical Centre

cClinical Trial Centre, University of Leipzig

dLeipzig Research Centre for Civilization Diseases, University of Leipzig

eInstitute for Medical Informatics, Statistics and Epidemiology, University of Leipzig

fInstitute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig

gMedical Department III-Endocrinology, Nephrology, Rheumatology, University of Leipzig, Germany

Received 19 June 2023 Accepted 17 July 2023.

Correspondence to Johannes Wiegand, Division of Hepatology, Department of Medicine II, Leipzig University Medical Centre, Liebigstraße 20, 04103 Leipzig, Germany, Tel: +49 341 97 12330; fax: +49 341 97 12339; e-mail: [email protected]

Comments (0)

No login
gif